The new bulk vaccine order placed with Bavarian Nordic for the ebola vaccine to which Johnson & Johnson holds the rights has positive signal value for investors, according to Senior Equity Analyst Søren Løntoft Hansen from the Danish bank Sydbank, following Bavarian Nordic's Tuesday announcement that the order amounted to USD 28m.
The Ebola vaccine was recommended for approval by the EU in May 2020 and finally approved in 2020. And in June 2020, already, Bavarian received an order worth USD 13.9m from Johnson & Johnson to produce and supply the ebola vaccine in bulk vaccines.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
Genmab to submit cancer candidate epcoritamab to the FDA before year-end
The US Food and Drug Administration will receive a marketing authorization application from Genmab and partner Abbvie in the second half of this year.
Novo Nordisk denied general conditional reimbursement for Wegovy in Denmark – again
The Danish Medicines Agency has been told for the second time that the price of the obesity drug is not in line with the effect it provides.
Bavarian Nordic is working with EMA on monkeypox vaccine label expansion
Bavarian Nordic’s smallpox vaccine Imvanex has previously been used off-label to protect close contacts from monkeypox in several countries. The Danish vaccine firm is now working with the EMA to expand the label in an ”accelerated process.”
Coloplast's climate goals approved by international initiative
The Science Based Targets initiative has approved Coloplast’s carbon emission reduction goals.
Top news from MedWatch this week
Miss anything?
KLIFO is looking for a Clinical Trial Assistant for our office in Glostrup, Lund or Münich 
Corporate Quality Compliance Specialists 
Chair of the Board 
Medical Advisor 
Senior Teaching Fellow for the BioMedical Design Novo Nordisk Foundation Fellowship Program 
Nordic Medical Advisor 
Clinical Project Leader/ Sr. Clinical Trial Manager – make a difference and join our mission to bring our IL-22 lead program to patients 
Director Regulatory Affairs 
Global Learning Specialist 
Senior DMPK Laboratory Technologist 
Regulatory Affairs Manager - Maternity Cover 
Project Mgr for Medical Device Development 
Senior Scientist for Analytical Development